Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.

West NR., Hegazy AN., Owens BMJ., Bullers SJ., Linggi B., Buonocore S., Coccia M., Görtz D., This S., Stockenhuber K., Pott J., Friedrich M., Ryzhakov G., Baribaud F., Brodmerkel C., Cieluch C., Rahman N., Müller-Newen G., Owens RJ., Kühl AA., Maloy KJ., Plevy SE., Oxford IBD Cohort Investigators None., Keshav S., Travis SPL., Powrie F.

DOI

10.1038/nm0617-788d

Type

Other

Publication Date

06/06/2017

Volume

23

Original publication